Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system

Pharmacology & Therapeutics
J M Witkin, D L Nelson

Abstract

Evidence exists to implicate the monoamine histamine in the control of arousal and cognitive functions. Antagonists of H(3) receptors are postsynaptic and presynaptic modulators of neural transmission in a variety of neuronal circuits relevant to cognition. Accumulating neuroanatomical, neurochemical, pharmacological, and behavioral data support the idea that H(3) receptor antagonists may function to improve cognitive performances in disease states (e.g., Alzheimer's disease and mild cognitive impairment states). Thus, H(3) receptor antagonists have been shown to increase performance in attention and memory tests in nonhuman experiments and prevent the degradation in performances produced by scopolamine, MK-801, or age. In contrast, agonists of the H(3) receptor generally produce cognitive impairing effects in animal models. The role of H(3) receptors in these behavioral effects is substantiated by data indicating a central origin for their effects, the selectivity of some of the H(3) receptor antagonists studied, and the pharmacological modification of effects of H(3) receptor antagonists by selective H(3) receptor agonists. Data and issues that challenge the potential role for H(3) receptor antagonists in cognitive processes ...Continue Reading

References

Jan 1, 1977·Annual Review of Pharmacology and Toxicology·J C Schwartz
Nov 1, 1991·Epilepsy Research·R ScherklH H Frey
Dec 1, 1988·British Journal of Pharmacology·S J Hill, R M Straw
Mar 1, 1989·Behavioral and Neural Biology·I Izquierdo
Dec 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·E SchlickerM Göthert
May 14, 1987·Nature·J M ArrangJ C Schwartz
May 27, 1986·European Journal of Pharmacology·R OishiK Saeki
May 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·E SchlickerM Göthert
Nov 1, 1971·European Journal of Pharmacology·J C SchwartzM Verdiere-Sahuque
May 1, 1995·Pharmacology, Biochemistry, and Behavior·P GhiP Portaleone
Apr 1, 1994·British Journal of Pharmacology·P Malmberg-AielloA Bartolini
Feb 1, 1993·Biological & Pharmaceutical Bulletin·C Kamei, K Tasaka
Feb 23, 1993·European Journal of Pharmacology·J Clapham, G J Kilpatrick
Jan 1, 1993·Journal of Neural Transmission. General Section·E SchlickerM Göthert
Mar 1, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·P Malmberg-AielloA Bartolini
Mar 28, 1998·Neuropharmacology·O SelbachH L Haas
Jun 3, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·P GhiL Molinengo
Feb 2, 2000·Neuroscience and Biobehavioral Reviews·M B PassaniP Blandina
Feb 23, 2000·Neuroreport·A Molina-HernándezJ A Arias-Montaño
Sep 8, 2000·Neuroreport·S Cassar
Dec 19, 2000·Biochemical and Biophysical Research Communications·T NakamuraK Tanaka
Oct 20, 2001·Behavioural Brain Research·L BacciottiniP Blandina
Jan 5, 2002·European Journal of Pharmacology·L Ireland-DennyA A Hancock
Jan 5, 2002·Expert Opinion on Investigational Drugs·S R Pliszka

❮ Previous
Next ❯

Citations

Dec 27, 2005·Drug Discovery Today·Sylvain CelanireIwan J P de Esch
Aug 7, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew G FoleyCiaran M Regan
Oct 3, 2008·Neuropsychiatric Disease and Treatment·J D Best, Wendy K Alderton
Jul 1, 2008·Expert Opinion on Drug Discovery·Roy YaariPierre N Tariot
Apr 6, 2011·Pharmacology, Biochemistry, and Behavior·Tanya L WallaceJoseph G Wettstein
Feb 15, 2011·Pharmacology, Biochemistry, and Behavior·Alvin V TerryScott J Webster
Aug 6, 2010·Brain Research Reviews·P Van RuitenbeekW J Riedel
May 25, 2010·Neuropharmacology·Farhad Jadidi-Niaragh, Abbas Mirshafiey
Jun 23, 2005·The Journal of Pharmacy and Pharmacology·H E BadenhorstS van Dyk
Jul 1, 2009·Human Psychopharmacology·Christopher J EdgarKeith A Wesnes
May 26, 2006·British Journal of Clinical Pharmacology·Elemer Szabadi
Feb 18, 2009·British Journal of Pharmacology·P van RuitenbeekW J Riedel
Nov 9, 2004·Trends in Pharmacological Sciences·Maria Beatrice PassaniPatrizio Blandina
Dec 1, 2005·European Journal of Pharmacology·Sayaka ItoShigeru Tokita
Nov 30, 2006·Biochemical Pharmacology·P BonaventureT Lovenberg
Jun 25, 2015·Neuropharmacology·Saara NuutinenPertti Panula
May 29, 2016·Progress in Neurobiology·S ButiniH Stark
Jun 16, 2016·Frontiers in Neuroscience·Mohammad A KhanfarHolger Stark
May 10, 2017·Translational Psychiatry·C WrightD R Weinberger
Jul 10, 2007·Bioorganic & Medicinal Chemistry Letters·Michael A LetavicNicholas I Carruthers
Feb 24, 2007·Bioorganic & Medicinal Chemistry Letters·John M KeithNicholas I Carruthers
Feb 20, 2007·Bioorganic & Medicinal Chemistry Letters·Michael A LetavicNicholas I Carruthers
Sep 5, 2008·Bioorganic & Medicinal Chemistry Letters·Makoto JitsuokaNagaaki Sato
Feb 10, 2006·Bioorganic & Medicinal Chemistry·Dorota ŁazewskaKatarzyna Kieć-Kononowicz
Jan 23, 2008·Journal of Psychopharmacology·P van RuitenbeekWj Riedel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.